Vesalius Biocapital III invests in European life sciences companies developing medicines, medical devices, diagnostics, and digital health technologies.
2017
Vesalius Biocapital III invests in European life sciences companies developing medicines, medical devices, diagnostics, and digital health technologies. The fund backs science-based innovation and entrepreneurs building healthcare products.
Its specialist team combines life sciences experience with venture capital, corporate finance, and strategy consulting expertise. The portfolio spans drug development, medical devices and diagnostics, and digital health, including the physician platform Tonic App.
Vesalius Biocapital III - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.
